Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Aug 26, 2020 10:32am
128 Views
Post# 31455061

RE:What is happening? LOL Bye Bye TV

RE:What is happening? LOL Bye Bye TVDoes anyone know what the reporting rules are for TV and Con on the Nasdaq given they have filed a shelf prospectus to sell their shares and warrants?

I know, it doesn't mean they are selling.  But do you know their reporting requirements under a shelf prospectus?


GunnerG wrote: NewcamoRealstups, I think you need to wake up to what is happening.  

168,735 warrants is what TV owns right now and 20,160,241 are the total the big boys own.

So much for NewcamoRealstupsMarcjohnson team and their rants about 85% ownership.  This isn't the company covering all bases doofus.  This is the big boys bailing.

Use of Proceeds below; selling shareholders (BIG BOYS) receive ALL the net proceeds, we (LMNL) will not receive anything, but we (LMNL) get to pay the costs incurred.

ROFLMAO

THE OFFERING

 

Common shares offered by the selling shareholders

20,160,241 common shares, including 168,735 common shares issuable upon exercise of the warrants.

 

 

Common shares to be outstanding after this offering

23,589,087 common shares (assuming the sale of all 20,160,241 common shares, including 168,735 common shares issuable upon exercise of the warrants by the selling shareholders).

 

 

Use of proceeds

The selling shareholders will receive all of the net proceeds from this offering. We will not receive any proceeds from the sale of common shares in this offering. We will, however, bear the costs incurred in connection with the registration of these common shares and, upon the exercise of the warrants, we will receive the exercise price of the warrants, which is $15.21 per common share.




<< Previous
Bullboard Posts
Next >>